Table 2.
Univariate analysis of risk factors for gallstone.
| No Gallstone (n = 2860) |
Gallstone (n = 178) |
p-Value | |
|---|---|---|---|
| Age, mean (SD) | 55.1 (8.3) | 57.4 (8.5) | <0.001 |
| Gender, no (%) | 0.750 | ||
| Female | 1178 (41.2) | 76 (42.7) | |
| Male | 1682 (58.8) | 102 (57.3) | |
| Waist circumference, cm, mean (SD) | 85.4 (8.1) | 87.1 (8.0) | 0.007 |
| SBP, no (%) | 0.018 | ||
| ≥140 mmHg | 335 (11.7) | 32 (18.0) | |
| <140 mmHg | 2525 (88.3) | 146 (82.0) | |
| Serum indices | |||
| Hb, g/dL, mean (SD) | 14.4 (1.5) | 14.3 (1.6) | 0.347 |
| Total bilirubin, mg/dL, mean (SD) | 0.9 (0.4) | 0.8 (0.3) | 0.107 |
| Direct bilirubin, mg/dL, mean (SD) | 0.3 (0.1) | 0.3 (0.1) | 0.166 |
| AST, IU/L, mean (SD) | 25.8 (13.8) | 26.4 (14.0) | 0.583 |
| ALT, IU/L, mean (SD) | 27.8 (18.2) | 30.4 (32.5) | 0.277 |
| γGTP, IU/L, mean (SD) | 41.3 (52.4) | 43.2 (61.6) | 0.683 |
| ALP, IU/L, mean (SD) | 65.3 (19.6) | 66.8 (18.6) | 0.333 |
| Total cholesterol, mg/dL, mean (SD) | 190.6 (37.8) | 187.8 (41.4) | 0.334 |
| TG, mg/dL, mean (SD) | 112.8 (76.6) | 117.4 (64.3) | 0.357 |
| HDL-C, mg/dL, mean (SD) | 53.7 (15.9) | 51.7 (15.6) | 0.110 |
| LDL-C, mg/dL, mean (SD) | 130.3 (35.0) | 127.6 (38.7) | 0.335 |
| FBG, mg/dL, mean (SD) | 95.4 (22.4) | 100.9 (26.0) | 0.007 |
| HbA1c, no (%) | <0.001 | ||
| ≥6.5 % | 272 (9.5) | 34 (19.1) | |
| <6.5% | 2588 (90.5) | 144 (80.9) | |
| CCTA indices | |||
| Sfat index, cm2/(kg/m2), mean (SD) | 5.9 (2.0) | 6.2 (2.1) | 0.068 |
| Vfat index, cm2/(kg/m2), mean (SD) | 4.5 (2.2) | 4.9 (2.3) | 0.018 |
| LAMA index, cm2/(kg/m2), mean (SD) | 1.2 (3.8) | 1.2 (0.3) | 0.881 |
| NAMA index, cm2/(kg/m2), mean (SD) | 4.5 (4.2) | 4.2 (1.2) | 0.015 |
| Vigorous exercise, no (%) | 0.015 | ||
| Less than 2 days in a week | 1996 (69.8) | 140 (78.7) | |
| 2 or more days in a week | 864 (30.2) | 38 (21.3) | |
| Univariate Analysis | |||
| OR (95% CI) | p-Values | ||
| Age, mean (SD) | 1.04 (1.02–1.05) | <0.001 | |
| Gender, no (%) | |||
| Female | 1 | ||
| Male | 0.94 (0.69–1.28) | 0.692 | |
| Waist circumference, cm, mean (SD) | 1.02 (1.01–1.04) | 0.007 | |
| SBP, no (%) | |||
| <140 mmHg | 1 | ||
| ≥140 mmHg | 1.65 (1.09–2.43) | 0.014 | |
| Serum indices | |||
| Hb, g/dL, mean (SD) | 0.95 (0.87–1.05) | 0.347 | |
| Total bilirubin, mg/dL, mean (SD) | 0.74 (0.48–1.10) | 0.152 | |
| Direct bilirubin, mg/dL, mean (SD) | 0.40 (0.11–1.37) | 0.162 | |
| AST, IU/L, mean (SD) | 1.00 (0.99–1.01) | 0.583 | |
| ALT, IU/L, mean (SD) | 1.01 (1.00–1.01) | 0.075 | |
| γGTP, IU/L, mean (SD) | 1.00 (1.00–1.00) | 0.638 | |
| ALP, IU/L, mean (SD) | 1.00 (1.00–1.01) | 0.332 | |
| Total cholesterol, mg/dL, mean (SD) | 1.00 (0.99–1.00) | 0.334 | |
| TG, mg/dL, mean (SD) | 1.00 (1.00–1.00) | 0.429 | |
| HDL-C, mg/dL, mean (SD) | 0.99 (0.98–1.00) | 0.110 | |
| LDL-C, mg/dL, mean (SD) | 1.00 (0.99–1.00) | 0.335 | |
| FBG, mg/dL, mean (SD) | 1.01 (1.00–1.01) | 0.002 | |
| HbA1c, no (%) | |||
| <6.5% | 1 | ||
| ≥6.5% | 2.25 (1.49–3.29) | <0.001 | |
| CCTA indices | |||
| Sfat index, cm2/(kg/m2), mean (SD) | 1.07 (0.99–1.15) | 0.068 | |
| Vfat index, cm2/(kg/m2), mean (SD) | 1.08 (1.01–1.15) | 0.018 | |
| LAMA index, cm2/(kg/m2), mean (SD) | 1.00 (1.00–1.02) | 0.968 | |
| NAMA index, cm2/(kg/m2), mean (SD) | 0.86 (0.76–0.98) | 0.021 | |
| Vigorous exercise, no (%) | |||
| Less than 2 days in a week | 1 | ||
| 2 or more days in a week | 0.63 (0.43–0.90) | 0.013 | |
SBP, systolic blood pressure; AST, aspartate aminotransferase; ALT, alanine aminotransferase; γGTP, gamma glutamyltransferase; ALP, alkaline phosphatase; FBG, fasting blood glucose; TG, triglyceride; HDL-C, high-density lipoprotein; LDL-C, low-density lipoprotein; CCTA, coronary CT angiography; Sfat, subcutaneous fat; Vfat, visceral fat; LAMA, low-attenuated muscle area; NAMA, normal-attenuated muscle area.